Literature DB >> 12878947

Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype.

Sunil Rangappa1, John W C Entwistle, Andrew S Wechsler, J Yasha Kresh.   

Abstract

BACKGROUND: Intercellular crosstalk and cellular plasticity are key factors in embryogenesis and organogenesis. The microenvironment plays a critical role in directing the progression of stem cells into differentiated cells. We hypothesized that intercellular interaction between adult human mesenchymal stem cells and adult human cardiomyocytes would induce stem cells to acquire the phenotypical characteristics of cardiomyocytes, and we tested the role that direct cell-to-cell contact plays in directing this differentiation process. Human mesenchymal stem cells were cultured in the presence of human cardiomyocytes ("coculture") or in the presence of media conditioned by separate cultures of human cardiomyocytes ("conditioned media").
METHODS: Human cardiomyocytes were labeled with chloromethyl derivatives of fluorescein diacetate. In the coculture experiments, human mesenchymal stem cells and human cardiomyocytes were mixed at a 1:1 ratio in smooth muscle 2 media and seeded at a cell density of 10,000 cells/cm(2). Cells were cocultured in an incubator at 37 degrees C for 48 hours. Subsequently, fluorescence-activated cell sorting was used to extract the differentiating human mesenchymal stem cells. In the conditioned media experiments, human mesenchymal stem cells were incubated in media previously conditioned by cardiomyocytes, in the presence and absence of serum (+/-serum). The conditioned media was changed 3 times, at intervals of 48 hours. Total RNA was isolated and reverse transcriptase-polymerase chain reaction was performed for expression of contractile proteins and cardiac specific genes. Immunostaining against myosin heavy chain, beta-actin troponin-T, and troponin-I was performed.
RESULTS: Fluorescence-activated cell sorting analysis identified 66% of the human mesenchymal stem cells in the G1 phase. Differentiated hMSCs from the coculture experiments expressed myosin heavy chain, beta-actin, and troponin-T by reverse transcriptase-polymerase chain reaction. Immunostaining was also positive against myosin heavy chain and troponin-T. In contrast, only beta-actin expression was observed in the human mesenchymal stem cells incubated with conditioned media +/- serum.
CONCLUSION: In addition to soluble signaling molecules, direct cell-to-cell contact is obligatory in relaying the external cues of the microenvironment controlling the differentiation of adult stem cells to cardiomyocytes. These data indicate that human mesenchymal stem cells are plastic and can be reprogrammed into a cardiomyogenic lineage that may be used in cell-based therapy for treating heart failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878947     DOI: 10.1016/s0022-5223(03)00074-6

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  37 in total

1.  Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes.

Authors:  Krishna C Vallabhaneni; Hermann Haller; Inna Dumler
Journal:  Stem Cells Dev       Date:  2012-07-13       Impact factor: 3.272

2.  Cardiac transcription factors driven lineage-specification of adult stem cells.

Authors:  Ana Armiñán; Carolina Gandía; José Manuel García-Verdugo; Elisa Lledó; José Luis Mullor; José Anastasio Montero; Pilar Sepúlveda
Journal:  J Cardiovasc Transl Res       Date:  2009-10-21       Impact factor: 4.132

3.  In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells.

Authors:  Sveva Bollini; Michela Pozzobon; Muriel Nobles; Johannes Riegler; Xuebin Dong; Martina Piccoli; Angela Chiavegato; Anthony N Price; Marco Ghionzoli; King K Cheung; Anna Cabrelle; Paul R O'Mahoney; Emanuele Cozzi; Saverio Sartore; Andrew Tinker; Mark F Lythgoe; Paolo De Coppi
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 4.  Mesenchymal stem cells for the treatment of heart failure.

Authors:  Shunsuke Ohnishi; Hajime Ohgushi; Soichiro Kitamura; Noritoshi Nagaya
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 5.  Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.

Authors:  Jakob Reiser; Xian-Yang Zhang; Charles S Hemenway; Debasis Mondal; Leena Pradhan; Vincent F La Russa
Journal:  Expert Opin Biol Ther       Date:  2005-12       Impact factor: 4.388

Review 6.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

7.  ADSCs differentiated into cardiomyocytes in cardiac microenvironment.

Authors:  Yanxia Zhu; Tianqing Liu; Kedong Song; Ruiming Ning; Xuehu Ma; Zhanfeng Cui
Journal:  Mol Cell Biochem       Date:  2008-12-24       Impact factor: 3.396

8.  Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells.

Authors:  Yasumasa Kuroda; Shohei Wakao; Masaaki Kitada; Toru Murakami; Makoto Nojima; Mari Dezawa
Journal:  Nat Protoc       Date:  2013-06-20       Impact factor: 13.491

Review 9.  Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis.

Authors:  Maria Grazia Perino; Satoshi Yamanaka; Jinliang Li; Anna M Wobus; Kenneth R Boheler
Journal:  J Mol Cell Cardiol       Date:  2008-05-11       Impact factor: 5.000

Review 10.  Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue.

Authors:  Maritza Mayorga; Amanda Finan; Marc Penn
Journal:  Stem Cell Rev Rep       Date:  2009-01-30       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.